In the case of miRNA-155, it has been suggested that EVs from breast cancer are emerging mediators of neoplastic cachexia [121], since they have an important role in the catabolism of adipocytes and muscle cells by targeting PPARγ (peroxisome proliferator-activated receptor gamma). Here, PPARG is linked to breast carcinoma.